Hideki Tokaibayashi

Direktor/Vorstandsmitglied bei TELLA, INC.

38 Jahre

Technology Services

Health Technology

Aktive Positionen von Hideki Tokaibayashi

Unternehmen	Position	Beginn	Ende
TELLA, INC.	Direktor/Vorstandsmitglied	01.03.2021	-
GranCharite Co. Ltd.	Direktor/Vorstandsmitglied	01.11.2017	-

Unternehmen	Position	Beginn	Ende
REMIXPOINT, INC.	Direktor/Vorstandsmitglied	01.06.2020	28.06.2022
REMIXPOINT, INC.	Independent Dir/Board Member	01.06.2020	28.06.2022

International

Japan

Operativ

Director/Board Member	3
Independent Dir/Board Member	1

Sektoral

Technology Services	2
Health Technology	2

Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Börsennotierte Unternehmen	1
REMIXPOINT, INC.	Technology Services

Private Unternehmen	2
tella, Inc. tella, Inc. BiotechnologyHealth Technology tella, Inc. engages in research and development of dendritic cell (DC) vaccine therapy. It operates through the following segments: Cell Medicine, Medical Support, and Pharmaceuticals. The Cell Medicine segment provides cancer treatment technology and know-hows centered on dendritic cell vaccine therapy. The Medical Support segment manages contact research organization (CRO) business and offers genetic testing services. The Pharmaceuticals segment deals with the development of dendritic cell vaccine as a cancer treatment. The company was founded by Yuichiro Yazaki on June 24, 2004 and is headquartered in Tokyo, Japan.	Health Technology
GranCharite Co. Ltd.

Private Unternehmen

Health Technology

GranCharite Co. Ltd.